JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harbison, R. D.
Right arrow Articles by Mantilla-Plata, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harbison, R. D.
Right arrow Articles by Mantilla-Plata, B.
Journal of Pharmacology And Experimental Therapeutics, Vol. 180, Issue 2, 446-453, 1972
Copyright © 1972 by American Society for Pharmacology and Experimental Therapeutics


PRENATAL TOXICITY, MATERNAL DISTRIBUTION AND PLACENTAL TRANSFER OF TETRAHYDROCANNABINOL

Raymond D. Harbison 1 and Bernardo Mantilla-Plata 1

1 Department of Pharmacology, School of Medicine, Tulane University, New Orleans, Louisiana

Dgr9-Tetrahydrocannabinol (Dgr9-THC) was embryo- or fetocidal when administered to pregnant mice. Dgr9-THC administered on days 8 and 9 of gestation produced about 70% incidence of in utero deaths. Dgr9-THC induced about 30% incidence of in utero deaths when administered on gestational days 10 and 11 or days 12 and 13. Dgr9-THC also significantly reduced fetal body weight. Again, there was a gestational period susceptibility. After i.p. administration of 14C-labeled Dgr9-THC, 14C was measured in maternal plasma. The greater accumulation of 14C was found in maternal fat and liver tissue. Smaller amounts of 14C were measured in maternal kidney, muscle and brain tissue. Dgr9-THC was transferred across the placenta and was measured in fetal tissue and amnionic fluid. Excretion of Dgr9-THC was primarily by feces and at 120 hours after injection about 10% of the dose remained in the animals. Maximum excretion of Dgr9-THC in the urine was about 10% of the administered dose. Thus, Dgr9-THC is transferred across the placenta and is embryocidal or fetocidal.

Submitted on August 2, 1971
Accepted on October 18, 1971




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
H. Wang, S. K. Dey, and M. Maccarrone
Jekyll and Hyde: Two Faces of Cannabinoid Signaling in Male and Female Fertility
Endocr. Rev., August 1, 2006; 27(5): 427 - 448.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
S Dalterio and A Bartke
Perinatal exposure to cannabinoids alters male reproductive function in mice
Science, September 28, 1979; 205(4413): 1420 - 1422.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1972 by the American Society for Pharmacology and Experimental Therapeutics.